Wolfe Research analyst Myles Walton downgrades Northrop Grumman (NYSE:NOC) from Outperform to Peer Perform.
CureVac Stock Drops After Final Results Confirm Its COVID-19 Vaccine Trails Rivals
The German biotech company CureVac BV (NASDAQ:CVAC) announced on Wednesday after hours the final results of its late-stage COVID-19 vaccine trial…